XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash Flows from Operating Activities:    
Net loss $ (475,976) $ (1,029,490)
Depreciation and amortization 679,882 713,557
Bad debt (benefit) (10,036) (5,521)
Inventory write off 10,164
Changes in assets and liabilities:    
Trade accounts and other receivables (434,306) 258,130
Advances to suppliers 91,388
Inventory (552,686) (447,745)
Trade accounts payable 100,539 (3,413)
Other payables and accrued expenses (450,887) (290,893)
Advances from customers (392,021) (74,814)
Prepaid expenses (24,111) (9,414)
Net Cash Used in Operating Activities (1,468,214) (879,439)
Cash Flows from Investing Activities:    
Purchases of property and equipment 55,964 (1,391)
Net Cash Provided By (Used In) Investing Activities 55,964 (1,391)
Cash Flows from Financing Activities:    
Payments of line of credit (47,241)
Proceeds from lines of credit 511,125  
Borrowings and interest from related party 7,112 7,669
Repayments to related party (236,206)
Net Cash Provided By (Used In) Financing Activities 518,237 (275,778)
Effect of Exchange Rate Changes on Cash 30,989 12,358
Net Decrease in Cash, Cash Equivalents and Restricted Cash (863,024) (1,144,250)
Cash and Cash Equivalents at Beginning of Period 2,029,971 4,859,060
Cash, Cash Equivalents and Restricted Cash at End of Period 1,166,947 3,714,810
Supplemental Cash Flow Information:    
Cash paid for income taxes
Cash paid for interest 22,928 218,232
Supplemental Noncash Investing and Financing Activities:    
Accounts receivable collected with banker’s acceptances 243,750 36,885
Inventory purchased with banker’s acceptances 222,875 114,471
Conversions of Note Payable to common stock $ 650,000 $ 300,000